Rolfe Lindsey
Insider CIK 1650504 · CLVS See Remarks · BCEL Director · CERO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2026-01-07 | 2026-01-09 | 690,900 | — | $0 | 690,900 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-05-30 | 2025-06-02 | 9,326 | — | $0 | 9,326 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-03-04 | 2025-03-06 | 17,923 | — | $0 | 17,923 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2025-02-24 | 2025-02-26 | 127,500 | — | $0 | 255,000 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-12-02 | 2024-12-04 | 127,500 | — | $0 | 127,500 | SEC↗ |
| CERO CERO THERAPEUTICS HOLDINGS | A Award deriv | 2024-03-25 | 2024-03-27 | 112,500 | — | $0 | 112,500 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-11-02 | 2022-11-03 | 1,908 | $0.98 | $1.9K | 111,419 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-11-02 | 2022-11-03 | 2,353 | $0.98 | $2.3K | 113,691 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-11-01 | 2022-11-03 | 3,749 | — | $0 | 3,750 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-11-01 | 2022-11-03 | 4,625 | — | $0 | 23,125 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-11-01 | 2022-11-03 | 3,749 | — | $0 | 113,327 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-11-01 | 2022-11-03 | 4,625 | — | $0 | 116,044 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-09-02 | 2022-09-06 | 2,545 | $1.20 | $3.1K | 109,578 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-09-01 | 2022-09-06 | 5,063 | — | $0 | 50,625 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-09-01 | 2022-09-06 | 5,063 | — | $0 | 112,123 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-08-02 | 2022-08-03 | 1,939 | $1.46 | $2.8K | 104,826 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-08-02 | 2022-08-03 | 2,391 | $1.46 | $3.5K | 107,060 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-08-01 | 2022-08-03 | 4,625 | — | $0 | 27,750 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-08-01 | 2022-08-03 | 3,749 | — | $0 | 7,499 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-08-01 | 2022-08-03 | 3,749 | — | $0 | 106,765 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-08-01 | 2022-08-03 | 4,625 | — | $0 | 109,451 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-06-02 | 2022-06-03 | 2,650 | $0.64 | $1.7K | 103,016 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-06-01 | 2022-06-03 | 5,062 | — | $0 | 55,688 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-06-01 | 2022-06-03 | 5,062 | — | $0 | 105,666 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-05-02 | 2022-05-03 | 2,348 | $1.97 | $4.6K | 100,604 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-05-02 | 2022-05-03 | 1,904 | $1.97 | $3.8K | 98,327 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-05-01 | 2022-05-03 | 4,625 | — | $0 | 32,375 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-05-01 | 2022-05-03 | 3,749 | — | $0 | 11,248 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-05-01 | 2022-05-03 | 4,625 | — | $0 | 102,952 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-05-01 | 2022-05-03 | 3,749 | — | $0 | 100,231 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-03-02 | 2022-03-03 | 360 | $1.87 | $673 | 86,817 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-03-02 | 2022-03-03 | 10,585 | $1.87 | $19.8K | 96,482 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-03-01 | 2022-03-03 | 688 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-03-01 | 2022-03-03 | 20,250 | — | $0 | 60,750 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 81,000 | — | $0 | 81,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-03-01 | 2022-03-03 | 688 | — | $0 | 87,177 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-03-01 | 2022-03-03 | 20,250 | — | $0 | 107,067 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-02-02 | 2022-02-03 | 2,021 | $1.94 | $3.9K | 84,357 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2022-02-02 | 2022-02-03 | 2,493 | $1.94 | $4.8K | 86,489 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-02-01 | 2022-02-03 | 3,750 | — | $0 | 14,997 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2022-02-01 | 2022-02-03 | 4,625 | — | $0 | 37,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-02-01 | 2022-02-03 | 4,625 | — | $0 | 88,982 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2022-02-01 | 2022-02-03 | 3,750 | — | $0 | 86,378 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-12-02 | 2021-12-03 | 346 | $3.00 | $1.0K | 82,628 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-12-01 | 2021-12-03 | 687 | — | $0 | 688 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-12-01 | 2021-12-03 | 687 | — | $0 | 82,974 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-11-02 | 2021-11-03 | 1,884 | $4.55 | $8.6K | 79,987 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-11-02 | 2021-11-03 | 2,325 | $4.55 | $10.6K | 82,287 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-11-01 | 2021-11-03 | 4,625 | — | $0 | 41,625 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-11-01 | 2021-11-03 | 3,749 | — | $0 | 18,747 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-11-01 | 2021-11-03 | 3,749 | — | $0 | 81,871 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-11-01 | 2021-11-03 | 4,625 | — | $0 | 84,612 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-09-02 | 2021-09-03 | 347 | $4.89 | $1.7K | 78,122 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-09-01 | 2021-09-03 | 688 | — | $0 | 1,375 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-09-01 | 2021-09-03 | 688 | — | $0 | 78,469 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-08-03 | 2021-08-03 | 2,317 | $4.82 | $11.2K | 77,781 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-08-03 | 2021-08-03 | 1,878 | $4.82 | $9.1K | 75,473 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-08-01 | 2021-08-03 | 3,749 | — | $0 | 22,496 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-08-01 | 2021-08-03 | 4,625 | — | $0 | 46,250 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-08-01 | 2021-08-03 | 3,749 | — | $0 | 77,351 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-08-01 | 2021-08-03 | 4,625 | — | $0 | 80,098 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2021-06-09 | 2021-06-11 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-06-03 | 2021-06-03 | 322 | $5.63 | $1.8K | 73,602 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-06-01 | 2021-06-03 | 687 | — | $0 | 2,063 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-06-01 | 2021-06-03 | 687 | — | $0 | 73,924 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-05-04 | 2021-05-04 | 2,015 | $5.54 | $11.2K | 71,098 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-05-04 | 2021-05-04 | 2,486 | $5.54 | $13.8K | 73,237 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-05-01 | 2021-05-04 | 3,749 | — | $0 | 26,245 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-05-01 | 2021-05-04 | 4,625 | — | $0 | 50,875 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-05-01 | 2021-05-04 | 4,625 | — | $0 | 75,723 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-05-01 | 2021-05-04 | 3,749 | — | $0 | 73,113 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-03-02 | 2021-03-03 | 315 | $6.29 | $2.0K | 69,022 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-03-02 | 2021-03-03 | 346 | $6.29 | $2.2K | 69,364 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 81,000 | — | $0 | 81,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-03-01 | 2021-03-03 | 625 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-03-01 | 2021-03-03 | 688 | — | $0 | 2,750 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-03-01 | 2021-03-03 | 625 | — | $0 | 69,337 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-03-01 | 2021-03-03 | 688 | — | $0 | 69,710 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-02-02 | 2021-02-03 | 9,822 | $7.97 | $78.3K | 68,712 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2021-02-02 | 2021-02-03 | 1,991 | $7.97 | $15.9K | 60,034 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-02-01 | 2021-02-03 | 18,500 | — | $0 | 55,500 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2021-02-01 | 2021-02-03 | 3,750 | — | $0 | 29,994 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-02-01 | 2021-02-03 | 18,500 | — | $0 | 78,534 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2021-02-01 | 2021-02-03 | 3,750 | — | $0 | 62,025 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-12-21 | 2020-12-23 | 3,438 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-12-21 | 2020-12-23 | 3,438 | — | $0 | 60,003 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-12-21 | 2020-12-23 | 1,728 | $5.68 | $9.8K | 58,275 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-12-15 | 2020-12-16 | 17,241 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2020-12-15 | 2020-12-16 | 14,153 | $5.11 | $72.3K | 56,565 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-12-15 | 2020-12-16 | 17,241 | $3.28 | $56.6K | 70,718 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-12-03 | 2020-12-07 | 625 | — | $0 | 625 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-12-03 | 2020-12-07 | 687 | — | $0 | 3,438 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-12-03 | 2020-12-07 | 346 | $4.89 | $1.7K | 53,477 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-12-03 | 2020-12-07 | 687 | — | $0 | 53,823 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-12-03 | 2020-12-07 | 315 | $4.89 | $1.5K | 53,136 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-12-03 | 2020-12-07 | 625 | — | $0 | 53,451 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-11-03 | 2020-11-05 | 3,749 | — | $0 | 33,744 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-11-03 | 2020-11-05 | 3,749 | — | $0 | 54,746 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-11-03 | 2020-11-05 | 1,920 | $4.93 | $9.5K | 52,826 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-09-21 | 2020-09-23 | 3,437 | — | $0 | 3,438 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-09-21 | 2020-09-23 | 21 | $6.86 | $144 | 52,723 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-09-21 | 2020-09-23 | 1,726 | $6.85 | $11.8K | 50,997 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-09-21 | 2020-09-23 | 3,437 | — | $0 | 52,744 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-09-03 | 2020-09-08 | 688 | — | $0 | 4,125 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-09-03 | 2020-09-08 | 625 | — | $0 | 1,250 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-09-03 | 2020-09-08 | 329 | $5.30 | $1.7K | 49,307 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-09-03 | 2020-09-08 | 688 | — | $0 | 49,636 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-09-03 | 2020-09-08 | 299 | $5.30 | $1.6K | 48,948 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-09-03 | 2020-09-08 | 625 | — | $0 | 49,247 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-08-03 | 2020-08-05 | 3,749 | — | $0 | 37,493 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-08-03 | 2020-08-05 | 3,749 | — | $0 | 50,521 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-08-03 | 2020-08-05 | 1,899 | $5.92 | $11.2K | 48,622 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-06-22 | 2020-06-23 | 3,438 | — | $0 | 6,875 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-06-22 | 2020-06-23 | 1,728 | $6.74 | $11.6K | 46,772 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-06-22 | 2020-06-23 | 3,438 | — | $0 | 48,500 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2020-06-10 | 2020-06-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-06-03 | 2020-06-05 | 687 | — | $0 | 4,813 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-06-03 | 2020-06-05 | 625 | — | $0 | 1,875 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-06-03 | 2020-06-05 | 625 | — | $0 | 45,055 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-06-03 | 2020-06-05 | 324 | $7.03 | $2.3K | 44,731 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-06-03 | 2020-06-05 | 687 | — | $0 | 45,418 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-06-03 | 2020-06-05 | 356 | $7.03 | $2.5K | 45,062 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-05-05 | 2020-05-07 | 3,749 | — | $0 | 41,242 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-05-05 | 2020-05-07 | 1,677 | $8.10 | $13.6K | 44,430 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-05-05 | 2020-05-07 | 3,749 | — | $0 | 46,107 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-04-06 | 2020-04-08 | 23,034 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-04-06 | 2020-04-08 | 23,034 | $3.08 | $70.9K | 59,091 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2020-04-06 | 2020-04-08 | 16,733 | $6.80 | $113.8K | 42,358 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-03-20 | 2020-03-23 | 3,437 | — | $0 | 10,313 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-03-20 | 2020-03-23 | 1,728 | $4.60 | $7.9K | 36,057 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-03-20 | 2020-03-23 | 3,437 | — | $0 | 37,785 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-03-03 | 2020-03-05 | 625 | — | $0 | 2,500 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-03-03 | 2020-03-05 | 688 | — | $0 | 5,500 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-03-03 | 2020-03-05 | 625 | — | $0 | 34,347 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-03-03 | 2020-03-05 | 327 | $7.20 | $2.4K | 34,020 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-03-03 | 2020-03-05 | 688 | — | $0 | 34,708 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-03-03 | 2020-03-05 | 360 | $7.20 | $2.6K | 34,348 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2020-02-04 | 2020-02-06 | 14,997 | — | $0 | 44,991 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2020-02-04 | 2020-02-06 | 7,503 | $8.41 | $63.1K | 33,722 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2020-02-04 | 2020-02-06 | 14,997 | — | $0 | 41,225 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 74,000 | — | $0 | 74,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-12-20 | 2019-12-26 | 3,438 | — | $0 | 13,750 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-12-20 | 2019-12-26 | 1,729 | $11.30 | $19.5K | 26,228 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-12-20 | 2019-12-26 | 3,438 | — | $0 | 27,957 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-12-03 | 2019-12-05 | 625 | — | $0 | 3,125 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-12-03 | 2019-12-05 | 687 | — | $0 | 6,188 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-12-03 | 2019-12-05 | 321 | $14.59 | $4.7K | 24,185 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-12-03 | 2019-12-05 | 625 | — | $0 | 24,506 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-12-03 | 2019-12-05 | 353 | $14.61 | $5.2K | 24,519 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-12-03 | 2019-12-05 | 687 | — | $0 | 24,872 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-09-20 | 2019-09-24 | 3,437 | — | $0 | 17,188 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-09-20 | 2019-09-24 | 1,744 | $4.80 | $8.4K | 23,881 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-09-20 | 2019-09-24 | 3,437 | — | $0 | 25,625 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-09-04 | 2019-09-06 | 688 | — | $0 | 6,875 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-09-04 | 2019-09-06 | 625 | — | $0 | 3,750 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-09-04 | 2019-09-06 | 688 | — | $0 | 22,563 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-09-04 | 2019-09-06 | 341 | $5.21 | $1.8K | 21,875 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-09-04 | 2019-09-06 | 625 | — | $0 | 22,216 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-09-04 | 2019-09-06 | 375 | $5.21 | $2.0K | 22,188 | SEC↗ |
| BCEL Atreca, Inc. | A Award deriv | 2019-08-22 | 2019-08-22 | 24,000 | — | $0 | 24,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-06-20 | 2019-06-24 | 3,438 | — | $0 | 20,625 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-06-20 | 2019-06-24 | 3,438 | — | $0 | 23,319 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-06-20 | 2019-06-24 | 1,728 | $14.70 | $25.4K | 21,591 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-06-04 | 2019-06-06 | 687 | — | $0 | 7,563 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-06-04 | 2019-06-06 | 625 | — | $0 | 4,375 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-06-04 | 2019-06-06 | 343 | $15.07 | $5.2K | 19,881 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-06-04 | 2019-06-06 | 687 | — | $0 | 20,224 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-06-04 | 2019-06-06 | 312 | $15.07 | $4.7K | 19,537 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-06-04 | 2019-06-06 | 625 | — | $0 | 19,849 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-03-20 | 2019-03-21 | 3,437 | — | $0 | 24,063 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-03-20 | 2019-03-21 | 3,437 | — | $0 | 20,953 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-03-20 | 2019-03-21 | 1,729 | $26.13 | $45.2K | 19,224 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-03-05 | 2019-03-06 | 2,750 | — | $0 | 8,250 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2019-03-05 | 2019-03-06 | 625 | — | $0 | 5,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-03-05 | 2019-03-06 | 1,410 | $29.29 | $41.3K | 17,516 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-03-05 | 2019-03-06 | 2,750 | — | $0 | 18,926 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2019-03-05 | 2019-03-06 | 321 | $29.29 | $9.4K | 16,176 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2019-03-05 | 2019-03-06 | 625 | — | $0 | 16,497 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2019-02-01 | 2019-02-04 | 59,988 | — | $0 | 59,988 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2019-02-01 | 2019-02-04 | 19,996 | — | $0 | 19,996 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-12-20 | 2018-12-26 | 3,438 | — | $0 | 27,500 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-12-20 | 2018-12-26 | 3,438 | — | $0 | 17,600 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2018-12-20 | 2018-12-26 | 1,728 | $17.72 | $30.6K | 15,872 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-12-04 | 2018-12-06 | 625 | — | $0 | 5,625 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-12-04 | 2018-12-06 | 625 | — | $0 | 14,446 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2018-12-04 | 2018-12-06 | 284 | $21.23 | $6.0K | 14,162 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-09-20 | 2018-09-24 | 3,437 | — | $0 | 30,938 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-09-20 | 2018-09-24 | 3,437 | — | $0 | 15,549 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-09-20 | 2018-09-24 | 1,728 | $32.21 | $55.7K | 13,821 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-09-05 | 2018-09-07 | 625 | — | $0 | 6,250 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-09-05 | 2018-09-07 | 321 | $35.75 | $11.5K | 12,112 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-09-05 | 2018-09-07 | 625 | — | $0 | 12,433 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-06-20 | 2018-06-21 | 3,438 | — | $0 | 34,375 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-06-20 | 2018-06-21 | 3,438 | — | $0 | 13,536 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-06-20 | 2018-06-21 | 1,728 | $45.75 | $79.1K | 11,808 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-06-06 | 2018-06-08 | 625 | — | $0 | 6,875 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-06-06 | 2018-06-08 | 316 | $47.70 | $15.1K | 10,098 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-06-06 | 2018-06-08 | 625 | — | $0 | 10,414 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-03-20 | 2018-03-21 | 3,437 | — | $0 | 37,813 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-03-20 | 2018-03-21 | 1,728 | $56.75 | $98.1K | 9,789 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-03-20 | 2018-03-21 | 3,437 | — | $0 | 11,517 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2018-03-07 | 2018-03-09 | 2,500 | — | $0 | 7,500 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2018-03-07 | 2018-03-09 | 1,260 | $58.43 | $73.6K | 8,080 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2018-03-07 | 2018-03-09 | 2,500 | — | $0 | 9,340 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2018-03-01 | 2018-03-02 | 11,000 | — | $0 | 11,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2018-03-01 | 2018-03-02 | 11,000 | — | $0 | 11,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2017-12-20 | 2017-12-21 | 13,750 | — | $0 | 41,250 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2017-12-20 | 2017-12-21 | 13,750 | — | $0 | 13,750 | SEC↗ |
| CLVS Clovis Oncology, Inc. | F Tax w/h | 2017-12-20 | 2017-12-21 | 6,910 | $63.80 | $440.9K | 6,840 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2017-03-27 | 2017-03-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2017-03-27 | 2017-03-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2016-12-19 | 2016-12-19 | 55,000 | — | $0 | 55,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2015-10-28 | 2015-10-30 | 4,000 | — | $0 | 23,034 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-10-28 | 2015-10-30 | 1,962 | $98.91 | $194.1K | 238 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2015-10-28 | 2015-10-30 | 4,000 | $3.08 | $12.3K | 4,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-10-28 | 2015-10-30 | 500 | $95.78 | $47.9K | 3,500 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-10-28 | 2015-10-30 | 238 | $99.22 | $23.6K | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-10-28 | 2015-10-30 | 1,300 | $97.31 | $126.5K | 2,200 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2015-10-05 | 2015-10-07 | 4,000 | — | $0 | 27,034 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-10-05 | 2015-10-07 | 2,221 | $93.01 | $206.6K | 722 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2015-10-05 | 2015-10-07 | 4,000 | $3.08 | $12.3K | 4,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-10-05 | 2015-10-07 | 1,057 | $91.84 | $97.1K | 2,943 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-10-05 | 2015-10-07 | 322 | $96.13 | $31.0K | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-10-05 | 2015-10-07 | 400 | $93.92 | $37.6K | 322 | SEC↗ |